About the symposium
The 6th annual Bringing Chemistry to Medicine Symposium featured talks by leading experts from around the globe working at the interface of chemical biology and biomedical sciences. Speakers represented expertise across various research areas, including therapeutic regulation of transcription and chromatin, AI, data science, and chemical biology.
The symposium was hosted by the St. Jude Chemical Biology and Therapeutics and the St. Jude Comprehensive Cancer Center. The event is designed to advance collaboration and engagement in the emerging field of transcription-targeted therapeutics.
2026 speakers
- Martin Burke, MD, PhD, University of Illinois Urbana-Champaign
- Benjamin Cravatt, PhD, Scripps Research
- Michael Erb, PhD, Scripps Research
- Fleur Ferguson, PhD, University of California San Diego
- Christoph Gorgulla, PhD, St. Jude Children's Research Hospital
- Laura Kiessling, PhD, Massachusetts Institute of Technology
- Christina Leslie, PhD, Memorial Sloan Kettering Cancer Center
- Lingyin Li, PhD, Stanford University
- Brian Liau, PhD, Harvard University
- Jian Ma, PhD, Carnegie Mellon University
- Paul Mischel, MD, Stanford University
- Brian Shoichet, PhD, University of California San Francisco
- Jussi Taipale, PhD, Wellcome Sanger Institute; Karolinska Institutet; University of Helsinki
- Christopher R. Vakoc, MD, PhD, St. Jude Children's Research Hospital
- Xiao Wang, PhD, Broad Institute of MIT and Harvard
- Richard Young, PhD, Massachusetts Institute of Technology
Overview
Event: Cells and Genomes in Space and Time, the 6th annual Bringing Chemistry to Medicine Symposium
Date: October 1-2, 2026
Location:
St. Jude Children's Research Hospital
Memphis, Tennessee, USA
Virtual option available
Department hosts: Chemical Biology & Therapeutics and the St. Jude Comprehensive Cancer Center
Event hosts:
Aseem Z. Ansari
Chair, Chemical Biology & Therapeutics
R. J. Ulrich Endowed Chair
Charles W. M. Roberts, MD, PhD
Executive Vice President
Director, Comprehensive Cancer Center
Mishtu Dey, PhD
Editor-in-Chief
Cell Chemical Biology
Cell Press
Lara Szewczak, PhD
Editor-in-Chief
Molecular Cell
Cell Press
Event contact:
Bringing Chemistry to Medicine planning committee
BC2M@stjude.org
Agenda
Watch our archived lectures
Each year since 2020, St. Jude has hosted exciting two-day events focused on Transcription Therapy and Chemical Biology and Therapeutics.
Past symposia
Transcription Therapy at St. Jude
Over decades of research, scientists in the St. Jude Comprehensive Cancer Center and others have discovered that several pediatric cancers emerge due to disruption in chromatin and epigenetic states and dysfunctional transcriptional regulation. While gene regulation in general has long been considered “undruggable,” scientists in the St. Jude Department of Chemical Biology & Therapeutics (CBT) have created synthetic gene regulators and are devising new chemical approaches to inhibit or degrade malfunctioning components of chromatin and gene regulatory machineries. This work builds on the history of St. Jude as a pioneer in the therapeutic use of small molecules targeting gene regulation, most notably the application of glucocorticoid receptor agonists into chemotherapy regimens for pediatric patients with acute lymphoblastic lymphoma (ALL). The drugging of this transcription factor helped to dramatically increase overall survival rates for newly diagnosed ALL to 94% at St. Jude.